Both in vivo and in vitro experimental results show that the expression of TrkB mRNA in human laryngeal cancer Hep2 cells is significantly increased, so in this study, Hep2 cells were used for subsequent experiments. This evidence concerns the gene NTRK2 and laryngeal carcinoma.